Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure. METHODS: After medical therapy was optimized, 258 patients who had heart failure (mean age [+/-SD], 63+/-10 years; ejection fraction, 24.5+/-7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40+/-16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained. RESULTS: Three months after undergoing randomization, the CPAP group, as compared with the control group, had greater reductions in the frequency of episodes of apnea and hypopnea (-21+/-16 vs. -2+/-18 per hour, P<0.001) and in norepinephrine levels (-1.03+/-1.84 vs. 0.02+/-0.99 nmol per liter, P=0.009), and greater increases in the mean nocturnal oxygen saturation (1.6+/-2.8 percent vs. 0.4+/-2.5 percent, P<0.001), ejection fraction (2.2+/-5.4 percent vs. 0.4+/-5.3 percent, P=0.02), and the distance walked in six minutes (20.0+/-55 vs. -0.8+/-64.8 m, P=0.016). There were no differences between the control group and the CPAP group in the number of hospitalizations, quality of life, or atrial natriuretic peptide levels. An early divergence in survival rates without heart transplantation favored the control group, but after 18 months the divergence favored the CPAP group, yet the overall event rates (death and heart transplantation) did not differ (32 vs. 32 events, respectively; P=0.54). CONCLUSIONS: Although CPAP attenuated central sleep apnea, improved nocturnal oxygenation, increased the ejection fraction, lowered norepinephrine levels, and increased the distance walked in six minutes, it did not affect survival. Our data do not support the use of CPAP to extend life in patients who have central sleep apnea and heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically a high loop gain can express itself as periodic breathing, for example, at high altitude,357 or in congestive heart failure (CHF).358,359”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [359]
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
McCullagh, P., & Nelder, J. A. (1983) · Springer eBooks · doi:10.1007/978-1-4899-3244-0 · Cited by 1,980
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
EEG Arousals: Scoring Rules and Examples
(1992) · Sleep · doi:10.1093/sleep/15.2.173 · Cited by 1,637
Research works printed but not linked: 4
- Bradley TD, 2001, Can J Cardiol, 17, 677
- Staats BA, 1984, Am Rev Respir Dis, 130, 59
- Johnstone DE, 1994, Can J Cardiol, 10, 613
- 10.1172/jci21748 · doi:10.1172/jci21748 · Paper page
Cited by
Items 201–300 of 1,000
Naughton, M. T., & Lorenzi‐Filho, G. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.02.001 · Cited by 68
Positive airway pressure therapy for heart failure
Kato, T., Suda, S., & Kasai, T. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i11.1175 · Cited by 64
Sleep disordered breathing: management update
Mohammadieh, A. M., Sutherland, K., & Cistulli, P. A. (2017) · Internal Medicine Journal · doi:10.1111/imj.13606 · Cited by 74
CSI position statement on management of heart failure in India
Guha, S., Harikrishnan, S., Ray, S., Sethi, R., Ramakrishnan, S., Banerjee, S., Bahl, V. K., Goswami, K. C., Banerjee, A. K., Shanmugasundaram, S., et al. (2018) · Indian Heart Journal · doi:10.1016/j.ihj.2018.05.003 · Cited by 65
“A Canadian trial found that patients randomized to CPAP had increased LVEF, improved nocturnal oxygenation and improved 6 min walk distance but no survival benefit was reported.(98) However, CPAP may be harmful in presence of central sleep apnoea.”
MethodCardiovascular Disorders Associated with Obstructive Sleep Apnea
(2011) · Advances in cardiology · doi:10.1159/000325110 · Cited by 65
Sleep Disordered Breathing and Heart Failure
Cowie, M., & Gallagher, A. M. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.06.016 · Cited by 70
(2006) · Cited by 58
Costanzo, M. R., Javaheri, S., Ponikowski, P. P., Oldenburg, O., Augostini, R. S., Goldberg, L. R., Stellbrink, C., Fox, H., Schwartz, A. R., Gupta, S. K., et al. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s300713 · Cited by 57
“Hypopnea Index (events/hour) 13 [4, 20] 9 [4, 17] 8 [4, 19] 5 [4, 11] 7 [4, 18] −3 [−9, 4] P=0.”
Sleep apnoea in heart failure: To treat or not to treat?
Naughton, M. T., & Kee, K. (2017) · Respirology · doi:10.1111/resp.12964 · Cited by 53
Neural respiratory drive during apnoeic events in obstructive sleep apnoea
Luo, Y., Wu, H., Tang, J., Jolley, C. J., Steier, J. S., Moxham, J., Zhong, N., & Polkey, M. I. (2007) · European Respiratory Journal · doi:10.1183/09031936.00049907 · Cited by 57
Sleep Disturbance in People With Heart Failure: Implications for Self-care
Redeker, N. S. (2008) · The Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000305094.20012.76 · Cited by 65
Gilmartin, G. S., McGeehan, B., Vigneault, K., Daly, R. W., Manento, M., Weiss, J. W., & THOMAS, R. J. (2010) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27984 · Cited by 60
Opioid-associated central sleep apnea: a case series
Alattar, M., & Scharf, S. M. (2008) · Sleep And Breathing · doi:10.1007/s11325-008-0221-7 · Cited by 57
“For CHF, BLV treatment may stabilize respiration or improve LV function by increasing intrathoracic pressure [20–23].”
BackgroundOlafiranye, O., Akinboboye, O., Mitchell, J. E., Ogedegbe, G. G., & Jean‐Louis, G. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.12.018 · Cited by 57
Ioachimescu, O. C., & Collop, N. A. (2012) · Neurologic Clinics · doi:10.1016/j.ncl.2012.08.003 · Cited by 64
“large, randomized, controlled trial assessing the role of CPAP in patients with CSA with a mean AHI of 40 and severe systolic CHF (Canadian Positive Airway Pressure) failed to show any survival benefit.(235) Overall death rate, transplant-free survival, and”
BackgroundCostanzo, M. R., Augostini, R. S., Goldberg, L. R., Ponikowski, P. P., Stellbrink, C., & Javaheri, S. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.08.344 · Cited by 57
Raising awareness about sleep disorders
Jaiswal, S. J., Owens, R. L., & Malhotra, A. (2017) · Lung India · doi:10.4103/0970-2113.205331 · Cited by 65
“HF such as nocturnal oxygenation and 6-min walk time, it does not appear to improve mortality.[52,53] Recently, a”
BackgroundIyngkaran, P., Liew, D., Neil, C., Driscoll, A. L., Marwick, T. H., & Hare, D. L. (2018) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546818809358 · Cited by 59
Edwards, B. A., Sands, S. A., Feeney, C., Skuza, E. M., Brodecky, V., Wilkinson, M. H., & Berger, P. J. (2009) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2009.07.006 · Cited by 55
“However, current evidence relating to the effectiveness of CPAP in treating CSA is contradictory, with some studies finding it is effective (Issa and Sullivan, 1986; Guilleminault et al., 1987; Naughton et al., 1994; Bradley et al., 2005) while others show it is not (Buckle et al.”
BackgroundGiannoni, A., Borrelli, C., Mirizzi, G., Richerson, G. B., Emdin, M., & Passino, C. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1854 · Cited by 53
Yadollahi, A., Gabriel, J. M., White, L. H., Taranto Montemurro, L., Kasai, T., & Bradley, T. D. (2014) · Sleep · doi:10.5665/sleep.4084 · Cited by 54
Self-citationJagielski, D., Ponikowski, P. P., Augostini, R. S., Kołodziej, A., Khayat, R., & Abraham, W. T. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.593 · Cited by 53
Zilberman, M., Silverberg, D. S., Bits, I., Steinbruch, S., Wexler, D., Sheps, D. S., Schwartz, D., & Oksenberg, A. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.034 · Cited by 56
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 67
Quality of life in patients with congestive heart failure and central sleep apnea
Carmona-Bernal, C., Ruiz-García, A., Villa-Gil, M., Sánchez‐Armengol, Á., Quintana‐Gallego, E., Ruiz, F. Ó., Barón‐Esquivias, G., & Capote, F. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.11.008 · Cited by 56
Treatment of Central Sleep Apnea in US Veterans
Chowdhuri, S., Ghabsha, A., Sinha, P., Kadri, M., Narula, S., & Badr, M. S. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2156 · Cited by 53
Ruttanaumpawan, P., Logan, A. G., Floras, J. S., Bradley, T. D., & for the CANPAP Investigators (2009) · Sleep · doi:10.5665/sleep/32.1.91 · Cited by 52
Self-citationKára, T., Novák, M., Nykodym, J., Bybee, K. A., Meluzı́n, J., Orban, M., Nováková, Z., Lipoldová, J., Hayes, D. L., Soucek, M., et al. (2008) · CHEST Journal · doi:10.1378/chest.07-2832 · Cited by 52
Insomnia and Depression: Birds of a Feather?
Perlis, M. L. (2007) · PsycEXTRA Dataset · doi:10.1037/e681482007-001 · Cited by 52
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2
Javaheri, S., Javaheri, S., Gozal, D., Campos‐Rodríguez, F., Martínez‐García, M. Á., Mokhlesi, B., Mehra, R., McNicholas, W. T., Somers, V. K., Zee, P. C., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.07.024 · Cited by 54
Quality of life assessment in heart failure interventions: a 10-year (1996–2005) review
Morgan, K., McGee, H. M., & Shelley, E. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32828622c3 · Cited by 58
Wang, C. C., Wu, C., Tsai, M., Lee, C., Huang, W. C., Chou, H., Huang, J. L., Chi, N., Yen, H., Tzeng, B., et al. (2019) · PubMed Central · doi:10.6515/acs.201905_35(3).20190422a · Cited by 54
Treatment of Cheyne‐Stokes Respiration Reduces Arrhythmic Events in Chronic Heart Failure
Bitter, T., Gutleben, K., Nölker, G., Westerheide, N., Prinz, C., Dimitriadis, Z., Horstkotte, D., Vogt, J., & Oldenburg, O. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12197 · Cited by 51
Wilson, M. A., Liberzon, I., Lindsey, M. L., Lokshina, Y., Risbrough, V. B., Sah, R., Wood, S. K., Williamson, J. B., & Spinale, F. G. (2019) · Stress · doi:10.1080/10253890.2019.1621283 · Cited by 49
“Unfortunately, in the Sleep Apnea Cardiovascular Endpoints (SAVE) trial, in which over 2700 patients were randomized to standard of care with and without CPAP, there was no relative reduction in major cardiovascular events (Bradley et al., 2005).”
BackgroundReal-Time Dynamic Carbon Dioxide Administration
Giannoni, A., Baruah, R., Willson, K., Mebrate, Y., Mayet, J., Emdin, M., Hughes, A. D., Manisty, C., & Francis, D. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.053 · Cited by 52
Sleep-disordered breathing and cardiovascular disease
Benjamin, J. A., & Lewis, K. E. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.062836 · Cited by 95
“When assessing differences in ejection fraction, it is important to note that 70% of subjects in this trial were prescribed b blockers (compared with 20% or less in previous studies) which may render some of the beneficial effects of CPAP on sympathetic activation redundant.(69) Others suggest that, although the preva…”
ResultCPAP and Bi-level PAP Therapy: New and Established Roles
Antonescu-Turcu, A., & Parthasarathy, S. (2010) · Respiratory Care · doi:10.4187/respcare.10551216 · Cited by 71
Mortality in sleep apnoea syndrome: a review of the evidence
Lavie, P. (2007) · European Respiratory Review · doi:10.1183/09059180.00010610 · Cited by 48
“A large-scale study investigating the effects of nCPAP treatment on survival of patients with central sleep apnoea and heart failure showed that even though CPAP attenuated central sleep apnoea and improved nocturnal oxygenation, it did not affect survival [ 31 ].”
BackgroundYoshihisa, A., Suzuki, S., Miyata, M., Yamaki, T., Sugimoto, K., Kunii, H., Nakazato, K., Suzuki, H., Saitoh, S., & Takeishi, Y. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0453 · Cited by 50
Pépin, J.-L., Muir, J.-F., Gentina, T., Dauvilliers, Y., Tamisier, R., Sapene, M., Escourrou, P., Fleury, B., Philip-Joet, F., Philip, P., et al. (2009) · Chest · doi:10.1378/chest.08-2646 · Cited by 46
Consequences of Obstructive Sleep Apnea
Khayat, R., & Pleister, A. P. (2016) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2016.05.002 · Cited by 52
Orr, J. E., Ayappa, I. A., Eckert, D. J., Feldman, J. L., Jackson, C. L., Javaheri, S., Khayat, R., Martin, J. L., Mehra, R., Naughton, M. T., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202101-0190st · Cited by 52
García‐Touchard, A., Somers, V. K., Olson, L. J., & Caples, S. M. (2008) · CHEST Journal · doi:10.1378/chest.07-0871 · Cited by 46
Vazir, A., Hastings, P. C., Papaioannou, I., Poole-Wilson, P. A., Cowie, M., Morrell, M. J., & Simonds, A. K. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.01.015 · Cited by 51
“In a more recent study, Tkacova and coworkers28 demonstrated that patients who shifted from having OSA to CSA over a mean of 7 months, had a significant drop in their end tidal PCO2 (PetCO2) during the night in which they had CSA.”
InfluentialObstructive sleep apnoea in adults
Usmani, Z. A., Chai‐Coetzer, C. L., Antic, N. A., & McEvoy, R. D. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2012-131340 · Cited by 54
Sharma, S., Mather, P. J., Gupta, A., Reeves, G. R., Rubin, S., Bonita, R. E., Chowdhury, A., Malloy, R., Willes, L., & Whellan, D. J. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.032 · Cited by 46
Upright Cheyne-Stokes Respiration in Patients With Heart Failure
Giannoni, A., Gentile, F., Sciarrone, P., Borrelli, C., Pasero, G., Mirizzi, G., Vergaro, G., Poletti, R., Piepoli, M. F., Emdin, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.033 · Cited by 45
Dimopoulos, S. K., Diakos, N., Tseliou, E., Tasoulis, A., Mpouchla, A., Manetos, C., Katsaros, L., Drakos, S. G., Terrovitis, J. V., & Nanas, S. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03215.x · Cited by 48
Desai, A. S., & Fang, J. C.-T. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2007.11.001 · Cited by 46
Steier, J. S., Jolley, C. J., Seymour, J. M., Teschler, H., Luo, Y., Polkey, M. I., & Moxham, J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00036210 · Cited by 50
Exercise training reverses exertional oscillatory ventilation in heart failure patients
Zurek, M., Corrà, U., Piepoli, M. F., Binder, R. K., Saner, H. E., & Schmid, J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00167011 · Cited by 44
Jagodich, T. A., Bersenas, A. M. E., Bateman, S. W., & Kerr, C. L. (2019) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12817 · Cited by 44
The Pathogenesis of Central and Complex Sleep Apnea
Roberts, E., Raphelson, J. R., Orr, J. E., LaBuzetta, J. N., & Malhotra, A. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01199-2 · Cited by 53
“Continuous positive airway pressure (CPAP) can improve breathing indices, but has not definitively been shown to improve mortality [52].”
Prevalence and Impact of Central Sleep Apnea in Heart Failure
Levy, P. A., Pépin, J., Tamisier, R., Neuder, Y., Baguet, J.-P., & Javaheri, S. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.08.001 · Cited by 46
Central sleep apnoea: not just one phenotype
Randerath, W. J., Baillieul, S., & Tamisier, R. (2024) · European Respiratory Review · doi:10.1183/16000617.0141-2023 · Cited by 45
“…the largest randomised control trial (RCT) investigating CSA associated with CHF proved that CPAP reduces the number of SRBDs by 50% and improves oxygen saturation, left ventricular ejection fraction, CHF status and 6-min walking test) and sympathetic tone, but has no effect on prognosis [109].”
BackgroundNoninvasive positive pressure ventilation for stable outpatients: CPAP and beyond
Theerakittikul, T., Ricaurte, B. M., & Aboussouan, L. S. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.10060 · Cited by 45
Effect of Adaptive Servo-Ventilation on 1-Year Prognosis in Heart Failure Patients
Takama, N., & Kurabayashi, M. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0299 · Cited by 43
Sustained 12 Month Benefit of Phrenic Nerve Stimulation for Central Sleep Apnea
Costanzo, M. R., Ponikowski, P. P., Javaheri, S., Augostini, R. S., Goldberg, L. R., Holcomb, R. G., Kao, A. C., Khayat, R., Oldenburg, O., Stellbrink, C., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.02.022 · Cited by 42
Sanchez, A. M., Germany, R. E., Lozier, M. R., Schweitzer, M. D., Kosseifi, S. G., & Anand, R. G. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100527 · Cited by 44
“There is emerging evidence implicating that CSA may be a marker of underlying cardiac dysfunction and even an independent pathologic factor, increasing the risk of death [21,23,26,27].”
BackgroundAdaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data
Tamisier, R., Damy, T., Bailly, S., Davy, J., Verbraecken, J. A., Lavergne, F., Palot, A., Goutorbe, F., d’Ortho, M., & Pépin, J. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217205 · Cited by 43
“15 19 Never-theless, some HF patient subgroup might benefit from the use of PAP, as suggested by a trend for improved outcomes in patients with HFpEF from”
BackgroundNoda, A., Izawa, H., Asano, H., Nakata, S., Hirashiki, A., Murase, Y., Iino, S., Nagata, K., Murohara, T., Koike, Y., et al. (2007) · CHEST Journal · doi:10.1378/chest.06-2271 · Cited by 46
Joho, S., Oda, Y., Ushijima, R., Hirai, T., & Inoue, H. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.08.360 · Cited by 42
“Treating CSA with continuous positive airway pressure (CPAP) decreases urinary catecholamine levels and increases ejection fraction, indicating that CSA contributes to sympathetic activation during sleep and to cardiac dysfunction.(9,10) However, because the apneahypopnea index (AHI) does not fall below 15 events per…”
BackgroundManagement of Heart Failure Patients with Reduced Ejection Fraction
Mann, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00028-7 · Cited by 51
Sleep apnea is a common and dangerous cardiovascular risk factor
Henning, R. J., & Anderson, W. M. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102838 · Cited by 46
Campbell, A. J., Ferrier, K. A., & Neill, A. M. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02623.x · Cited by 41
Terziyski, K. V., & Draganova, A. I. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_146 · Cited by 45
Treatment of Cheyne–Stokes respiration–central sleep apnea in patients with heart failure
Momomura, S. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2011.12.008 · Cited by 48
Linz, D., Fox, H., Bitter, T., Spießhöfer, J., Schöbel, C., Skobel, E. C., Türoff, A., Böhm, M., Cowie, M., Arzt, M. E., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-0970-4 · Cited by 43
Management of Mechanical Ventilation in Decompensated Heart Failure
Kuhn, B. T., Bradley, L., Dempsey, T. M., Puro, A., & Adams, J. Y. (2016) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd3040033 · Cited by 41
“4%), improved nocturnal oxygenation, and lower endogenous norepinephrine levels, but no change in survival [50].”
BackgroundSleep Breathing Disorders in Heart Failure
Coniglio, A. C., & Mentz, R. J. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.08.009 · Cited by 43
Maeder, M. T., Ammann, P., Münzer, T., Schoch, O. D., Korte, W. C., Hürny, C., MYERS, J. N., & Rickli, H. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.040 · Cited by 44
“While previous studies have investigated the effects of nCPAP on left ventricular function and exercise capacity in HF patients with concomitant OSA [8,31] and patients with HF and associated central sleep apnea [32], data on the impact of nCPAP therapy on functional capacity in patients with OSA in the absence of HF…”
BackgroundResolution of central sleep apnoea following implantation of a left ventricular assist device
Vazir, A., Hastings, P. C., Morrell, M. J., Pepper, J., Henein, M. Y., Westaby, S., Poole-Wilson, P. A., Cowie, M., & Simonds, A. K. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.06.072 · Cited by 40
“The optimal treatment of CSA remains unclear in light of results of the CANPAP study [3].”
BackgroundTelemedicine in Sleep-Disordered Breathing
Verbraecken, J. A. (2021) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2021.05.009 · Cited by 41
Nocturnal oxygen therapy in patients with chronic heart failure and sleep apnea: a systematic review
Bordier, P., Lataste, A., Hofmann, P., Robert, F., & Bourenane, G. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.10.017 · Cited by 41
“Concerning CSA/CSR in particular, beneficial effects have also been reported, for example with medication recommended in CHF [11,15], cardiac resynchronization therapy [16], and nocturnal oxygen therapy (NOT) [17,18].”
BackgroundInfluentialClinical review: Long-term noninvasive ventilation
Robert, D., & Argaud, L. (2007) · Critical Care · doi:10.1186/cc5714 · Cited by 38
“In addition, a recent large study comparing oxygen and CPAP, which also alleviates apnea and improves cardiac function, does not prove the clinical superiority of CPAP in terms of survival [49].”
BackgroundDrager, L. F., Lorenzi‐Filho, G., Cintra, F. D., Pedrosa, R. P., Bittencourt, L., Poyares, D. R., Gonzaga, C. C., Togeiro, S. M., Santos‐Silva, R., de Bruin, P. F. C., et al. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180154 · Cited by 85
Giannoni, A., Gentile, F., Navari, A., Borrelli, C., Mirizzi, G., Catapano, G. A., Vergaro, G., Grotti, F., Betta, M., Piepoli, M. F., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012419 · Cited by 40
“The strength of the pathophysiological model is key to guide experiments designed to challenge the model’s assumption and to provide optimal treatments for patients with a disease.32 On the other hand, if a treatment is not strongly pathophysiologically based and referred to a solid model, the randomized controlled tr…”
BackgroundInfluentialBrazilian Thoracic Association Consensus on Sleep-disordered Breathing
Duarte, R., Togeiro, S. M., Palombini, L., Rizzatti, F. P. G., Fagondes, S. C., Magalhães-da-Silveira, F. J., Cabral, M. M., Genta, P. R., Lorenzi‐Filho, G., Clímaco, D. C. S., et al. (2022) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20220106 · Cited by 51
“(246,247) The addition of oxygen therapy is indicated if PSG demonstrates episodes of nocturnal desaturation associated with central events.”
BackgroundObesity, Sleep Apnea Syndrome, and Rhythmogenic Risk
Grimm, W., & Becker, H. F. (2006) · Herz · doi:10.1007/s00059-006-2800-3 · Cited by 43
Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis
Chan, C. T., Notarius, C. F., Merlocco, A. C., & Floras, J. S. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm368 · Cited by 42
“the use of continuous positive airway pressure in heart failure patients [46]) which significantly improve quality of life.”
BackgroundSelf-citationCarnevale, C., Georges, M., Rabec, C. A., Tamisier, R., Levy, P. A., & Pépin, J. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.07.008 · Cited by 37
“Central sleep apnea (CSA) was diagnosed if the number of respiratory events per hour was P15 and at least 50% of the total AHI was central in origin [14].”
BackgroundMethodInfluentialDistinguishing central from obstructive hypopneas on a clinical polysomnogram
Javaheri, S., Rapoport, D. M., & Schwartz, A. R. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10420 · Cited by 37
Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failure
Kourouklis, S. P., Vagiakis, E., PARASKEVAIDIS, I. A., Farmakis, D. T., Κostikas, Κ., Parissis, J., Katsivas, A. G., Kremastinos, D. T., ANASTASIOU‐NANA, M. I., & Filippatos, G. S. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.101 · Cited by 43
“In the last few years a novel therapeutic modality, ASV, has been studied in these patients and the data indicate greater effectiveness and compliance with ASV compared to PAP, associated with significant improvement in LV systolic performance, loading conditions, neurohormonal activation and exercise tolerance [7,11–…”
MethodResultBündchen, D. C., Gonzáles, A. I., Noronha, M. A. D., Brüggemann, A. K. V., Sties, S. W., & de Carvalho, T. (2014) · Brazilian Journal of Physical Therapy · doi:10.1590/bjpt-rbf.2014.0039 · Cited by 44
Optimal NIV Medicare Access Promotion: Patients With COPD
Hill, N. S., Criner, G. J., Branson, R. D., Celli, B. R., MacIntyre, N. R., Sergew, A., Gay, P. C., Owens, R. L., Wolfe, L. F., Benditt, J. O., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.082 · Cited by 39
Ventilatory Abnormalities During Exercise in Heart Failure: A Mini Review
Arena, R. A., Guazzi, M., & MYERS, J. N. (2007) · Current Respiratory Medicine Reviews · doi:10.2174/157339807781387517 · Cited by 38
“Other therapeutic approaches, such as application of continuous positive airway pressure, theophylline and oxygen supplementation, may also positively impact EPB given the effectiveness of these interventions on CSA [70-72].”
BackgroundThe Year in Heart Failure 2005
Massie, B. M., & Force, T. L. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.01.001 · Cited by 36
Management of Noncardiac Comorbidities in Chronic Heart Failure
Chong, V., Singh, J. S., Parry, H., Saunders, J., Chowdhury, F., MANCINI, D. M., & Lang, C. C. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12141 · Cited by 36
“016), the transplant-free survival and rates of CHF-related hospitalizations were unaffected [46].”
BackgroundEnhancement of Cardiac Performance by Bilevel Positive Airway Pressure Ventilation in Heart Failure
Yoshida, M., Kadokami, T., Momii, H., Hayashi, A., Urashi, T., Narita, S., Kawamura, N., & Ando, S. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.10.009 · Cited by 35
Ferreira, S., Marinho, A., Patacho, M., Clara, E. S., Carrondo, M. C., Winck, J. C., & Bettencourt, P. (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-9 · Cited by 40
Ambient assistance service for fall and heart problem detection
Makhlouf, A., Boudouane, I., Saadia, N., & Ramdane-Chérif, A. (2018) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-018-0724-4 · Cited by 36
Orlova, Y. A., Tkacheva, O. N., Arutyunov, G. P., Kotovskaya, Y. V., Lopatin, Y. M., Mareev, V. Y., Mareev, Y. V., Рунихина, Н. К., Skvortsov, A. A., Strazhesko, I. D., et al. (2018) · Kardiologiia · doi:10.18087/cardio.2560 · Cited by 35
The role of acetazolamide in sleep apnea at sea level: a systematic review and meta-analysis
Ni, Y.-N., Yang, H., & THOMAS, R. J. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9116 · Cited by 36
“12 Adaptive servo-ventilation is an approved option for CSA, but ef fi cacy is inconsistent, 13,14 and sleep quality improvements are inferior to that achieved with CPAP in patients with OSA.”
Ishikawa, O., & Oks, M. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.04.009 · Cited by 39
Obstructive sleep apnea and cardiovascular risk.
Dorasamy, P. (2007) · PubMed Central · Cited by 37
Effects of obstructive sleep apnea treatment on left atrial volume and left atrial volume index
Khan, A., Latif, F., Hawkins, B. M., Tawk, M. M., Sivaram, C. A., & Kinasewitz, G. T. (2007) · Sleep And Breathing · doi:10.1007/s11325-007-0142-x · Cited by 34
“Treatment with CPAP has been shown to decrease cardiovascular mortality [3, 4, 11], improve control of hypertension [5, 12, 22], systolic dysfunction [5, 17], diastolic dysfunction [6], and pulmonary hypertension [18] in patients with OSA.”
BackgroundHypopnea definitions, determinants and dilemmas: a focused review
Shamim-Uzzaman, Q. A., Singh, S., & Chowdhuri, S. (2018) · Sleep Science and Practice · doi:10.1186/s41606-018-0023-1 · Cited by 34
Treatment of complex sleep apnea syndrome
Kuźniar, T. J., & Morgenthaler, T. I. (2008) · Current Treatment Options in Neurology · doi:10.1007/s11940-008-0036-7 · Cited by 34
Non-invasive positive ventilation in the treatment of sleep-related breathing disorders
Robert, D., & Argaud, L. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.03.009 · Cited by 33
“Even more, the largest study comparing O2 and CPAP, which also alleviate apnea and improve cardiac function, does not prove the clinical superiority of CPAP even if apneas are significantly diminished [95].”
BackgroundBadr, M. S., Khayat, R., Allam, J. S., Hyer, S., Mustafa, R., Naughton, M. T., Patil, S. P., Pien, G. W., Randerath, W. J., & Won, C. H. J. (2025) · SLEEP · doi:10.1093/sleep/zsag091.0683 · Cited by 45
Metadata
- Authors
- Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Tomlinson, G., & Floras, J. S.
- Affiliations
- University of Toronto (CA)
- McGill University (CA)
- Université Laval (CA)
- Dalhousie University (CA)
- Western University (CA)
- University of Calgary (CA)
- University of Regensburg (DE)
- University of British Columbia (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-10
- Volume
- 353
- Issue
- 19
- Pages
- 2025-2033
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130637800
- Semantic Scholar
- 266ff6f4028ab04f061c1b59c2a17a2fc2990e32
- Cited by
- 1,189
- References
- 45
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 33 · 2023: 47 · 2022: 45 · 2021: 51 · 2020: 40 · 2019: 55 · 2018: 50 · 2017: 70 · 2016: 87 · 2015: 68 · 2014: 44 · 2013: 67 · 2012: 62
- FWCI
- 45.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- continuous positive airway pressure, central sleep apnea, heart failure, nocturnal oxygen saturation, norepinephrine, ejection fraction, exercise capacity, neurohormones, atrial natriuretic peptide, quality of life, heart transplantation, sleep-disordered breathing, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction
- MeSH terms
- Aged, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Norepinephrine, Stroke Volume, Survival Rate, Proportional Hazards Models, Heart Transplantation, Treatment Outcome, Exercise Tolerance, Sleep Apnea, Central, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.